Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Monday, December 14, 2009, 10:43PM ET - U.S. Markets Closed. Dow Up 0.28% Nasdaq Up 0.99%
Hemobiotech Inc. (HMBT.OB)At 1:06PM ET: 0.35   0.00 (0.00%)  
MORE ON HMBT.OB
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Hemobiotech Inc.
5001 Spring Valley Road
Suite 1040 West
Dallas, TX 75244
United States - Map
Phone: 972-455-8950
Fax: 972-455-8951
Web Site: http://www.hemobiotech.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:4

BUSINESS SUMMARY 
HemoBioTech, Inc. engages in the research and development of human blood substitute technology licensed from Texas Tech University Health Service Center in Texas. It focuses primarily on the development of HemoTech, an oxygen-carrying solution that performs like red blood cells. The company was incorporated in 2003 and is headquartered in Dallas, Texas.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Hemobiotech Inc.


    KEY EXECUTIVES 
     PayExercised
    Dr. Arthur P. Bollon Ph.D., 64
    Chief Exec. Officer, Pres
    N/A N/A
    Mr. Ghassan Nino CPA, CMA, 41
    Founder and Vice Chairman
    $ 15.00KN/A
    Mr. Mark J. Rosenblum CPA, 55
    Chief Financial Officer and Sec.
    N/A N/A
    Dr. Mario Feola M.D., 82
    Chief Medical Officer
    N/A N/A
    Dr. Jan Simoni Ph.D., DVM, 57
    Acting VP, Principal Investigator of R&D and Advisor
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis